A new implant for keratoconus to avoid corneal transplant
Part of Eyes & vision clinical trials.
This trial tests a small metal implant placed in the cornea to treat keratoconus, a condition where the cornea thins and bulges. The goal is to see if the implant can safely improve vision and prevent the need for a corneal transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your cornea must be at least 350 micrometers thick at its thinnest point.
- Your vision with glasses must be poor (0.30 logMAR or worse), but improving significantly with special contact lenses.
- Your keratoconus must be considered advanced (stage 3–4) and stable for at least 12 months.
- You must not have an allergy to nickel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether prescription inserts placed in the cornea can improve day-to-day vision for people with keratoconus whose vision is getting worse and who have few options left. You may be able to avoid or delay corneal transplant depending on your cornea shape and thickness.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
This study tests tiny plastic rings (called Intacs) that are placed in the cornea to help reshape it and improve vision. It is for people with a condition called corneal ectasia, where the cornea thins and bulges, and who are otherwise facing a cornea transplant.
This study tests whether treating donor corneal tissue with a special light and vitamin drops (called cross-linking) before a transplant helps improve outcomes for people with keratoconus. If you need a corneal transplant, this could strengthen the donor tissue and potentially reduce the need for future procedures.
This study follows people with or at risk for keratoonus, a condition where the cornea thins and bulges. It aims to improve early detection and understand how the disease progresses.
This trial uses donated corneal tissue that was treated with a special light and riboflavin (collagen cross-linking) to strengthen it before transplant. The goal is to improve vision in people with severe keratoconus, a condition where the cornea bulges into a cone shape and gets very thin.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.